RE:RE:RE:Approved - SO WHY DID THEY SELL TO KEDRION?The money was always on 4050 kidney and liver.and yet they put IPF out in the presentations as their lead indication only to pull it. This action alone tells me that Tomfvck is playing the long game here and will go back to Boehringher and another at the table in 2018 and sell it to highest bidder. No way that they hang around for another 2-3 years for kidney and liver results.
stockman6767 wrote: The only place my mind goes on this is some very nefarious underhanded and under the table doings. I can not come up with any logical, legitimate reason for their actions since they took over the company.